|
Volumn 36, Issue 12, 2008, Pages 630-635
|
Parkinson's disease
a,b a,b |
Author keywords
basal ganglia; bradykinesia; dementia; dopamine; dyskinesia; extrapyramidal; non motor symptoms; Parkinson's disease; tremor
|
Indexed keywords
AMANTADINE;
APOMORPHINE;
BENSERAZIDE PLUS LEVODOPA;
CABERGOLINE;
CARBIDOPA PLUS LEVODOPA;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLONAZEPAM;
CO CARELDOPA;
DONEPEZIL;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
LEVODOPA;
MELATONIN;
MONOAMINE OXIDASE INHIBITOR;
ORPHENADRINE;
PERGOLIDE;
PRAMIPEXOLE;
RASAGILINE;
RIVASTIGMINE;
ROPINIROLE;
ROTIGOTINE;
SELEGILINE;
TOLCAPONE;
TRIHEXYPHENIDYL;
UNCLASSIFIED DRUG;
AGITATION;
ANKLE EDEMA;
ANOSMIA;
APATHY;
BRAIN DEPTH STIMULATION;
CAREGIVER SUPPORT;
CEREBELLUM DISEASE;
CLINICAL FEATURE;
CONFUSION;
DEMENTIA;
DEPRESSION;
DIARRHEA;
DIFFERENTIAL DIAGNOSIS;
DIFFUSE LEWY BODY DISEASE;
DISEASE COURSE;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSKINESIA;
ENVIRONMENTAL FACTOR;
ESSENTIAL TREMOR;
GENETIC SUSCEPTIBILITY;
HALLUCINATION;
HEREDITY;
HUMAN;
HYPERSEXUALITY;
HYPOSMIA;
IMPULSE CONTROL DISORDER;
INCIDENCE;
INJECTION SITE REACTION;
LIVEDO RETICULARIS;
MOOD DISORDER;
MORTALITY;
NAUSEA;
NEUROIMAGING;
NORMOTENSIVE HYDROCEPHALUS;
ORTHOSTATIC HYPOTENSION;
PARKINSON DISEASE;
PARKINSONISM;
PATHOGENESIS;
PATHOLOGICAL GAMBLING;
PREVALENCE;
PRIORITY JOURNAL;
PSYCHOSIS;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SIDE EFFECT;
SLEEP DISORDER;
SOMNOLENCE;
TREMOR;
URINARY DYSFUNCTION;
VISUAL HALLUCINATION;
VIVID DREAM;
VOMITING;
XEROSTOMIA;
|
EID: 57049115423
PISSN: 13573039
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mpmed.2008.09.004 Document Type: Review |
Times cited : (8)
|
References (10)
|